logo
MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

Yahoo12-05-2025

LYON, France, May 12, 2025--(BUSINESS WIRE)--Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, announced additional findings following full data readout for the exploratory single-arm, open-label Phase 1b clinical trial named IASO (NCT05889572) evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS).
In November 2024, the Company announced that the trial had met its primary endpoint assessing the safety and tolerability of MaaT033 with multiple doses, following the independent Data Safety and Monitoring Board (DSMB) conclusion. As a reminder, the exploratory Phase 1b trial enrolled a total of 15 participants across two centers in France Hôpital de la Pitié-Salpêtrière – AP-HP and the University Hospital of Lille. An external Scientific Advisory Committee took place at the end of March 2025 to review the full data. Below are the key takeaways from the Committee's review:
MaaT033 demonstrated a favorable safety and tolerability profile, supported by biomarker and microbiome analyses.
A rapid and sustained engraftment of bacterial species from MaaT033 was observed, mostly occurring within the first month and maintained during the 1-month follow-up period.
A slower rate of disease progression (based on ALSFRS-R slopes) was noted to be interpreted with caution given the short follow up, limited sample size and single-arm Phase 1b design. The ALSFRS-R is a standard functional scale in ALS trials to track the progression of the disease. The slope reflects how many points are "lost" (=disease progression) per month. In the final data readout for the IASO trial, the following was observed for the ALSFRS-R Total score slope:
From first symptoms to baseline, the median slope was –0.7 points/month (range: –1.2 to –0.3)
From baseline to Day 84 (D84), the median slope slowed to –0.3 points/month (range: –2.4 to +1.0)
No variation at D84 in the levels of neurofilaments, a marker associated with neuronal injury in ALS.
In addition, the Scientific Advisory Committee provided insights regarding the best population to target in a Phase 2 trial.
"These encouraging findings from the IASO Phase 1b trial confirm the favorable safety and tolerability profile of MaaT033 in ALS patients. They also highlight the therapeutic potential of microbiome modulation beyond oncology and open new avenues for development in neurodegenerative diseases, as evidence continues to grow around the gut-brain connection," said Gianfranco Pittari, MD, PhD, Chief Medical Officer of MaaT Pharma.
The study was conducted in close collaboration with the French patient association Tous en Selles contre la SLA (TECS), highlighting the essential role of patients and their advocates in advancing science, and with the support of experts from the French academic networks FILSLAN and ACT4ALS-MND.
"Recognizing the significant unmet medical need in ALS and with the will to support those affected, we applied our discovery platform to this new disease area, demonstrating its potential beyond our primary focus in oncology with encouraging Phase 1 data. In light of the Company's strict financial discipline, and considering the recent successes achieved in oncology, we are actively seeking partners with a focus on ALS and the financial capacity to support new options to fight this disease," stated Hervé Affagard, CEO and co-founder of MaaT Pharma.
–--
About MaaT033MaaT033, a standardized, donor-derived, high-richness, high-diversity oral Microbiome Ecosystem TherapyTM containing anti-inflammatory ButycoreTM species, is currently being developed as an adjunctive therapy to improve overall survival in patients receiving HSCT and other cellular therapies. MaaT033 is developed with the "pooling" technology, which allows pooling donations from multiple donors to create a standardized product with high microbial richness and diversity. It aims to ensure optimal microbiota function and to address a larger patient population in a chronic setting. MaaT033 has been granted Orphan Drug Designation by the European Medicines Agency (EMA).
About Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease in the US and Charcot's disease in Europe, is a progressive neurodegenerative disorder affecting motor neurons in the brain and spinal cord. This leads to muscle weakness, loss of voluntary movement, and eventually, paralysis and on an average lead to death in 3 to 5 years. ALS could affect up to 60,000 patients in US and EU by 2040 and has currently no curative treatment and few symptomatic treatments.
About MaaT PharmaMaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France.As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.
Forward-looking StatementsAll statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice and (ii) factors beyond the Company's control. These statements may include, without limitation, any statements preceded by, followed by, or including words such as "target," "believe," "expect," "aim", "intend," "may," "anticipate," "estimate," "plan," "project," "will," "can have," "likely," "should," "would," "could" and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company's control that could cause the Company's actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250511855391/en/
Contacts
MaaT Pharma – Investor RelationsGuilhaume DEBROAS, Ph.D.Head of Investor Relations+33 6 16 48 92 50invest@maat-pharma.com
MaaT Pharma – Media RelationsPauline RICHAUDSenior PR & Corporate Communications Manager+33 6 14 06 45 92media@maat-pharma.com
Rx Communications Group – U.S. Investor Relations Michael MillerManaging Director+1-917-633-6086mmiller@rxir.com
Catalytic Agency – U.S. Media Relations Heather SheaMedia relations for MaaT Pharma +1 617-286-2013 heather.shea@catalyticagency.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Second-Gen Stelvio on Hold as Alfa Romeo 'Reworks' EV Plans
Second-Gen Stelvio on Hold as Alfa Romeo 'Reworks' EV Plans

The Drive

time22 minutes ago

  • The Drive

Second-Gen Stelvio on Hold as Alfa Romeo 'Reworks' EV Plans

The latest car news, reviews, and features. The Alfa Romeo Stelvio has been with us for eight years now. It landed shortly after the brand's reintroduction to North America in 2015, and while it's outsold the Giulia sedan practically every year since it came out, the Stelvio never really provided the push expected from the company's first SUV. Naturally, people are looking to the next generation to right the ship, but if comments from Alfa leadership today are any indication, we could be waiting a while until we see it. During a Q&A session about the automaker's collaboration with the Luna Rossa sailing team this morning, Santo Ficili, CEO of Alfa Romeo and Maserati, briefly fielded a question about the upcoming SUV. 'You know, the transition throughout electrification is not going with the speed we were imagining last period, so now we are changing, totally, our path following the specific requests of our customers,' Ficili said. 'So the future of Alfa Romeo will be not only BEV, but we are working to evolve also [the internal combustion] engine powertrain, PHEV, and MHEV. In this sense, we are reworking our plan. As soon as we will be ready, of course we will launch also the new Stelvio.' This isn't much of a surprise, though it is somewhat disappointing. Last month, Reuters reported that the new SUV's launch had been postponed, citing 'tepid demand for electric vehicles.' Alfa was expected to lead with a battery electric version of the Stelvio, which will be built on Stellantis' STLA Large platform, just like the Dodge Charger. Taking that report and Ficili's comments together, it sounds like Alfa has decided to give itself more time to introduce a hybrid model concurrently with the EV. Reuters' sources told the news agency that the second-gen Stelvio now likely won't begin deliveries until September 2026 at the earliest. Meanwhile, the current Stelvio has certainly begun to show its age. It still looks solid, especially thanks to a refresh last year, but it's struggling to keep pace with the latest competitors from Alfa's luxury rivals in Germany. Unfortunately for the storied Italian automaker, its savior isn't exactly waiting in the wings. Got a tip? Send us a note: tips@

Phillies Make $800,000 Announcement During Win Over Cubs
Phillies Make $800,000 Announcement During Win Over Cubs

Yahoo

time28 minutes ago

  • Yahoo

Phillies Make $800,000 Announcement During Win Over Cubs

Phillies Make $800,000 Announcement During Win Over Cubs originally appeared on Athlon Sports. As it turns out, Brandon Marsh and the Philadelphia Phillies weren't the only ones celebrating at Citizens Bank Park on Monday night. Advertisement Midway through a 4-3, 11-inning win over the Chicago Cubs, the Phillies announced they'd raised over $800,000 on ALS Night. The Phillies thanked Asplundh, a Pennsylvania-based environmental services company, for their help. Asplundh donated $365,000 in honor of former executive Scott Asplundh, who is battling ALS, also known as Lou Gehrig's disease. 'Tonight's event was about giving hope to the brave individuals and their families who are affected by ALS,' Phillies owner John Middleton said. Philadelphia Phillies outfielder Brandon Marsh celebrates with teammates after hitting an 11th-inning single to beat the Cubs 4-3 on June 10, Ross-Imagn Images 'We thank our fans, and especially Asplundh, for all their support as we aim to find a cure for this terrible disease,' Middleton added. Advertisement The Phillies announced that they've raised nearly $24 million to fight ALS since 1984. Major League Baseball celebrated Lou Gehrig Day on June 2, the 84th anniversary of Gehrig's passing. On the field, the Phillies gave those in attendance — including an 'ALS Lineup of Courage' featuring those affected by the disease — a night to remember. Down 3-2 in the 11th, the Phillies tied the game on a single by J.T. Realmuto. Bryson Stott legged out a bunt single, and rookie third baseman Otto Kemp completed a three-hit night with a bunt single of his own, loading the bases. That set the stage for Marsh's walk-off single. The slumping Marsh went 2-for-3 off the bench and ended the Phillies' five-game losing streak. Related: Phillies Suggested to Make 'Extreme' Brandon Marsh Move Amid Losing Streak Related: Trade Idea Swaps Phillies' Andrew Painter for $3.85 Million Outfielder This story was originally reported by Athlon Sports on Jun 10, 2025, where it first appeared.

Austria hit by rare school shooting
Austria hit by rare school shooting

CNN

time28 minutes ago

  • CNN

Austria hit by rare school shooting

Austria hit by rare school shooting A gunman in Austria opened fire on a school in the southern city of Graz, killing himself and at least nine others. The death toll includes teenagers between the ages of 14 and 18, the Austrian interior ministry said. CNN's Frederik Pleitgen reports. 01:05 - Source: CNN Why China doesn't need the US auto market If there is one thing to be learned from Auto Shanghai - China's largest automobile show - it's that China has dozens of car brands that can rival Western ones. BYD surpassed Tesla's profits, but other EVs like those made by Zeekr, Xiaomi and Chery are quickly joining the race. CNN's Marc Stewart took a rare test drive of Zeekr's new 7GT. 00:44 - Source: CNN Analysis: Trump is in a crisis of his own making Trump tells President Vladimir Putin to stop after Russia launched its deadliest wave of attacks on Kyiv in nine months. This comes days after Trump said the US would walk out on efforts to make a peace deal in Ukraine if it didn't see progress. CNN's Nick Paton Walsh breaks down the latest. 01:03 - Source: CNN Russia launches strikes across Ukraine Russia launched waves of drones and ballistic missiles at multiple targets across a broad swath of Ukraine overnight killing at least four people in the capital Kyiv and wounding around 40 across the country. 00:32 - Source: CNN German leader on 'terrible' impact of Trump's tariffs In an interview with CNN's Jake Tapper, German Chancellor Friedrich Merz talks about the impact President Trump's tariffs are having on the auto industry. 01:13 - Source: CNN Greta Thunberg sails to Gaza Greta Thunberg has set sail with eleven other activists to Gaza. The activist group they're part of, The Freedom Flotilla Coalition, is attempting to bring aid and raise international awareness over the ongoing humanitarian crisis in the territory. 00:59 - Source: CNN Record rain floods Mexico City, traps people Mexico City was hit with record rainfall that didn't relent for more than five hours Monday night, marking the heaviest rain since 2017, according to water management officials. CNN's Valeria León walks a flooded avenue of the nation's capital after emergency crews worked through the night to rescue several trapped drivers. 00:43 - Source: CNN Gaza aid distribution turns deadly for third consecutive day For a third consecutive day, Palestinians came under fire while trying to receive aid from a distribution site in Gaza. According to the Palestinian Ministry of Health and Nasser hospital, at least 27 people were killed and dozens injured on June 3. 00:56 - Source: CNN Analysis: Why Ukraine's drone attack on Russia just changed the world CNN's Jim Sciutto explains why Ukraine's large-scale drone attack on Russian air bases thousands of miles behind the front lines struck fear into the heart of every global superpower 01:05 - Source: CNN Tomatoes fly at Colombia's largest food fight Around 20,000 revellers gathered in Sutamarchán, Colombia, to throw over 45 tonnes of tomatoes at each other. The Gran Tomatina festival, now in its 15th year, is hosted to celebrate the economy of Sutamarchán, which is centred around tomato production. Mayor Miguel Andrés Rodríguez said "between 70 and 80 percent of families [in Sutamarchán] live off tomatoes. This is a tribute to them." The festival uses tomatoes which are overripe, or otherwise not suitable for consumption. 00:30 - Source: CNN Palestinians shot dead near Gaza aid hub The Palestinian health ministry, hospital officials and multiple eyewitnesses say deadly gunfire killed dozens of Palestinians near an aid distribution site in Gaza on Sunday, with Israel's military denying that its troops fired 'within or near' the aid site. CNN Jerusalem correspondent Jeremy Diamond brings you up to speed on what we know about the weekend chaos. 02:31 - Source: CNN Palestinians describe deadly shooting near aid center in Gaza CNN spoke to multiple witnesses who recounted the deadly chaos that unfolded near a US-backed aid center in southern Gaza after more than 30 Palestinians were killed and dozens injured on Sunday, according to the Palestinian Ministry of Health. The health ministry blamed the Israeli military for the deaths while other witnesses claimed that local security personnel had also opened fire. Gaza Humanitarian Foundation, which runs the aid center, said there had been no gunfire at the site and Israel Defense Forces denied firing on civilians at or close to the site, calling such accusations 'false reports.' 00:55 - Source: CNN Palestinian UN envoy breaks down talking about Gaza's children The Palestinian ambassador to the UN made an emotional address, saying more than 1,300 children have been killed in Gaza since Israel ended the ceasefire in March. 01:19 - Source: CNN Political candidate wears body armor daily CNN's David Culver met César Gutiérrez Priego as he was readying to campaign for office in Mexico City. Gutiérrez Priego, who is running for a seat on the Supreme Court in Mexico, shows Culver the safety precautions he takes with political violence in Mexico at an all-time high. See Culver's full reporting on CNN. 00:53 - Source: CNN Harvard students and faculty speak out against Trump Harvard students and faculty spoke to CNN ahead of commencement as Donald Trump said the university should cap foreign enrollment. The Trump administration has recently sought to cancel $100 million in contracts with the school. 02:03 - Source: CNN Palestinians desperate for food rush US-backed aid site Scores of people rushed over fencing and through barricades in southern Gaza on the first day a US-Israeli-backed aid site was opened. CNN's Jeremy Diamond explains the desperate humanitarian situation that remains in the region. 01:22 - Source: CNN Journalists spit on at Jerusalem Day flag march Ultra-nationalist Israeli Jews chanted anti-Arab slogans as they marched through Jerusalem's Old City to mark Jerusalem Day. CNN's Oren Liebermann describes heavy police presence on the ground. Members of the crowd were seen spitting on journalists, including a CNN producer. 01:50 - Source: CNN Finland's president responds to Russian military activity along border CNN's Erin Burnett speaks with Finland's President Alexander Stubb about his country ramping up its military to deter potential Russian aggression. 02:16 - Source: CNN King Charles stresses Canada's 'self determination' amid pressure from US King Charles III delivered the ceremonial Speech from the Throne in the Canadian Senate. The address marks only the second time in Canadian history that the reigning sovereign has opened parliament, and the third time that the British monarch has delivered the address. 00:42 - Source: CNN Huge ship refloated after nearly crashing into house A larger container ship has been refloated after nearly crashing into a house in Norway. According to local police, the navigator had fallen asleep at the helm. 00:42 - Source: CNN Vehicle plows into crowd in Liverpool Police in the United Kingdom say a man has been arrested after a car plowed into Liverpool fans celebrating during the soccer club's Premier League trophy parade. 01:14 - Source: CNN

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store